Transactions
Gryphon Investors acquired Synteract
Sep. 2008
Client: Synteract is a mid-sized Contract Research Organization (CRO) focused on central nervous system (CNS) and Oncology Trials
Role: Edgemont Partners acted as exclusive financial advisor to Gryphon Investors in its acquisition of Synteract from Celerity Partners
Location: Carlsbad, CA
Sector: Pharmaceutical Services
Lead Banker: David Blume